Narayana Health Q2 FY27: operating revenue up 73.0% YoY to ₹ 28,440 Mn with UK consolidation; targets 7,800+ beds by FY30
Q2 FY27 consolidated operating revenue ₹ 28,440 Mn, up 73.0% YoY; EBITDA ₹ 6,054 Mn (21.3%), PAT ₹ 3,012 Mn up 16.6%.
By ScoutQuest · · 1 min read
- Consolidated operating revenue
- ₹ 28,440 Mn in Q2 FY27, up 73.0% YoY and 6.0% QoQ
- EBITDA
- ₹ 6,054 Mn (21.3% margin)
- PAT
- ₹ 3,012 Mn (10.6% margin)
- Period
- Q2 FY27 (quarter ended 30th Sep 2026)
- Positioning
- Narayana Health describes itself as a network of 56 healthcare facilities with 6,119 operational beds across India, the Cayman Islands and the United Kingdom, with ~21,150 staff.
📈 Consolidated operating revenue reached ₹ 28,440 Mn in Q2 FY27, up 73.0% YoY and 6.0% QoQ, with EBITDA of ₹ 6,054 Mn (21.3% margin) and PAT of ₹ 3,012 Mn (10.6% margin). NH India revenue grew 16.6% YoY to ₹ 14,402 Mn and India hospitals EBITDA margin rose to 26.8%.
📉 Cayman operations (HCCI) grew revenue 28.2% YoY to $63.4 Mn, while the UK business weakened: revenue slipped 0.9% QoQ to GBP 64.4 Mn, post-IFRS EBITDA fell 18.5% to GBP 4.7 Mn and PAT was a loss of GBP 2.7 Mn, including a GBP 0.8 Mn new centre loss.
🏭 The company says it is building to strengthen its presence in flagship regions, listing six projects (HSR and Central and South Bangalore, Rajarhat and Park Street Kolkata, Raipur) with completion dates FY28-FY30 and a stated bed capacity target of 7,800+ by FY30.
🎯 Net debt stood at ₹ 18,830 Mn as on 30th September 2026, a net debt to equity ratio of 0.38, with part of the debt denominated in USD and GBP. Management also presents Banashankari as a fully digital hospital model and lists ESG targets to 2030.
Also from Narayana Hrudayalaya
Q2 FY27 results: consolidated revenue ₹ 28,440 Mn, EBITDA up 42.0% YoY; earnings call on November 2
30 Oct 2026
Board approves Q2 and H1 FY27 results; auditor's review conclusion unmodified
30 Oct 2026
Narayana Hrudayalaya to host conference call on Nov 2, 2026 at 3:00 PM IST to discuss Q2/H1 FY27 results
26 Oct 2026
More numbers
- Consolidated operating revenue, Q2 FY27₹ 28,440 Mn
- Operating revenue growth YoY, Q2 FY27+73.0%
- Consolidated EBITDA, Q2 FY27₹ 6,054 Mn
- EBITDA margin, Q2 FY2721.3%
- Consolidated PAT, Q2 FY27₹ 3,012 Mn
- Group PAT growth YoY, Q2 FY2716.6%
- Consolidated net debt, 30 Sep 2026₹ 18,830 Mn
- NH India operating revenue, Q2 FY2714,402 (₹ Mn)
- India hospitals EBITDA margin, Q2 FY2726.8%
- Shareholder equity, 30 Sep 202650,054 (₹ Mn)
- Operational beds6,119
- Greenfield/Inorganic capex, FY27 (P)4,600 (INR Mn)
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.